Changzhou Bioregen biopharmaceutical co.,LTD.
百瑞吉
Changzhou Bioregen biopharmaceutical co.,LTD.
Biotech/Healthcare
Bairuiji is a Sino-foreign joint-venture high-tech startup. Its main business is the R&D, production, and sale of novel biomedical materials and sustained-release drug formulations, addressing difficult clinical needs in ENT, obstetrics and gynecology, general surgery, and orthopedics.
Latest round: Series E (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-02-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.